Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (32)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  2. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452

  3. Ivermectin resistance mechanisms in ectoparasites: a scoping review

    Parasitology Research, Vol. 123, Núm. 5

  4. Longitudinal Cough Frequency Monitoring in Persistent Coughers: Daily Variability and Predictability

    Lung, Vol. 202, Núm. 5, pp. 561-568

  5. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  6. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial

    International Journal of Infectious Diseases, Vol. 148

  7. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

    Microorganisms, Vol. 12, Núm. 4

  8. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain

    Journal of Hospital Infection, Vol. 151, pp. 173-185

2023

  1. A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors

    Malaria Journal, Vol. 22, Núm. 1

  2. Alternative approaches for creating a wealth index: The case of Mozambique

    BMJ Global Health, Vol. 8, Núm. 8

  3. BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators

    Malaria Journal, Vol. 22, Núm. 1

  4. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  5. Burden and risk factors of snakebite in Mopeia, Mozambique: Leveraging larger malaria trials to generate data of this neglected tropical disease

    PLoS Neglected Tropical Diseases, Vol. 17, Núm. 8

  6. Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.

    Parasites and Vectors, Vol. 16, Núm. 1

  7. Ivermectin as a novel malaria control tool: Getting ahead of the resistance curse

    Acta Tropica, Vol. 245

  8. Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study

    Nature Communications, Vol. 14, Núm. 1

  9. Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186

  10. Optimization of the molecular diagnosis of the acute hepatitis E virus infection

    Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332

  11. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

    Malaria Journal, Vol. 22, Núm. 1

  12. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34